ES2072666T3 - Esteres de acidos n-alquil 1,4-dihidropiridindicarboxilicos. - Google Patents

Esteres de acidos n-alquil 1,4-dihidropiridindicarboxilicos.

Info

Publication number
ES2072666T3
ES2072666T3 ES92112355T ES92112355T ES2072666T3 ES 2072666 T3 ES2072666 T3 ES 2072666T3 ES 92112355 T ES92112355 T ES 92112355T ES 92112355 T ES92112355 T ES 92112355T ES 2072666 T3 ES2072666 T3 ES 2072666T3
Authority
ES
Spain
Prior art keywords
acid
esters
dihydropyridindicarboxyl
alkyl
acid esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92112355T
Other languages
English (en)
Inventor
Bruno Dr Rosen
Siegfried Dr Zaiss
Hartmund Dr Wollweber
Hans-Georg Dr Dellweg
Jonge Maarten Dr De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2072666T3 publication Critical patent/ES2072666T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

ESTERES DEL ACIDO 1,4 LADOS PUEDEN FABRICARSE BIEN POR TRANSFORMACION DE ALDEHIDOS CON ESTERES ACETICOS Y AMINAS, DADO EL CASO, CON AISLAMIENTO DE LOS CORRESPONDIENTES COMPUESTOS DE ILIDENO, O POR TRANSFORMACION DE ESTERES DEL ACIDO AMINOCROTONICO CON COMPUESTOS DE ILIDENO Y ALQUILACION SUCESIVA DE LA FUNCION NH. LOS ESTERES DEL ACIDO 1,4 CARSE COMO SUSTANCIAS ACTIVAS EN PRODUCTOS FARMACEUTICOS, ESPECIALMENTE CON PRODUCTOS TERAPEUTICOS CEREBRALES.
ES92112355T 1991-07-31 1992-07-20 Esteres de acidos n-alquil 1,4-dihidropiridindicarboxilicos. Expired - Lifetime ES2072666T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4125271A DE4125271A1 (de) 1991-07-31 1991-07-31 Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester

Publications (1)

Publication Number Publication Date
ES2072666T3 true ES2072666T3 (es) 1995-07-16

Family

ID=6437351

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92112355T Expired - Lifetime ES2072666T3 (es) 1991-07-31 1992-07-20 Esteres de acidos n-alquil 1,4-dihidropiridindicarboxilicos.

Country Status (18)

Country Link
US (1) US5328931A (es)
EP (1) EP0525568B1 (es)
JP (1) JPH05194395A (es)
KR (1) KR930002316A (es)
AT (1) ATE122341T1 (es)
AU (1) AU646349B2 (es)
CA (1) CA2074777A1 (es)
CZ (1) CZ233492A3 (es)
DE (2) DE4125271A1 (es)
DK (1) DK0525568T3 (es)
ES (1) ES2072666T3 (es)
FI (1) FI923423A7 (es)
HU (1) HUT65434A (es)
IE (1) IE922512A1 (es)
IL (1) IL102670A0 (es)
MX (1) MX9204238A (es)
NO (1) NO177094B (es)
ZA (1) ZA925726B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342196A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
DK0595164T3 (da) * 1992-10-30 1997-05-26 Bayer Ag 4-Heterocyclophenyl-substituerede dihydropyridiner
DE4342195A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Dihydropyridine mit heterocyclisch substituierten Estern
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
DE59410255D1 (de) * 1993-12-10 2003-04-17 Bayer Ag Phenyl-substituierte 1,4-Dihydropyridine mit cerebraler Aktivität
DE4430092A1 (de) * 1994-08-25 1996-02-29 Bayer Ag 2,3-Cyclisch kondensierte 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2003099790A1 (en) * 2002-05-29 2003-12-04 Council Of Scientific And Industrial Research Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents
WO2019104041A1 (en) * 2017-11-21 2019-05-31 Michael Ohlmeyer Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
DE2210667A1 (de) * 1972-03-06 1973-09-20 Bayer Ag Kondensiert aromatisch substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
DK142287A (da) * 1986-03-27 1987-09-28 Byk Gulden Lomberg Chem Fab Optisk aktive 1,4-dihydropyridinderivater
FR2596760B1 (fr) * 1986-04-02 1988-12-09 Sori Soc Rech Ind Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procedes de preparation et utilisation en therapeutique
DE3888144T2 (de) * 1987-12-29 1994-06-23 Fujisawa Pharmaceutical Co Gehirn-Neuron schützendes Mittel, enthaltend eine Dihydropyridin-Verbindung.
AU650567B2 (en) * 1988-09-06 1994-06-23 Davis, Warren L. Dental syringe tip and adaptor
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IE922512A1 (en) 1993-02-10
DK0525568T3 (da) 1995-10-09
DE59202132D1 (de) 1995-06-14
EP0525568A1 (de) 1993-02-03
CZ233492A3 (en) 1993-05-12
US5328931A (en) 1994-07-12
AU646349B2 (en) 1994-02-17
FI923423L (fi) 1993-02-01
DE4125271A1 (de) 1993-02-11
MX9204238A (es) 1993-01-01
NO922852D0 (no) 1992-07-17
AU2048392A (en) 1993-02-04
JPH05194395A (ja) 1993-08-03
HUT65434A (en) 1994-06-28
NO922852L (no) 1993-02-01
ATE122341T1 (de) 1995-05-15
FI923423A7 (fi) 1993-02-01
NO177094B (no) 1995-04-10
CA2074777A1 (en) 1993-02-01
KR930002316A (ko) 1993-02-22
FI923423A0 (fi) 1992-07-29
IL102670A0 (en) 1993-01-14
HU9202489D0 (en) 1992-10-28
EP0525568B1 (de) 1995-05-10
ZA925726B (en) 1993-03-10

Similar Documents

Publication Publication Date Title
ES2122076T3 (es) Derivados de nor-acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
NO891962L (no) Substituerte 4-(kinolin-2-yl-metoksy)fenyl-eddiksyrederivater.
ES2135429T3 (es) Derivados de ciclohexano sustituidos para el tratamiento de enfermedades.
ATE65397T1 (de) Pharmazeutische zusammensetzungen mit gehalt an einem derivat der 3-hydroxy-buttersaeure, ausgewaehlt aus den oligomeren dieser saeure und den estern dieser saeure oder dieser oligomere mit dem 1,3-butan-diol.
NO934706D0 (no) Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
IT8224665A0 (it) Acidi alfa-arilalcanoici e loro derivati in forma otticamente attiva, particolarmente utili come medicamenti e procedimento per laloro preparazione.
ES2072666T3 (es) Esteres de acidos n-alquil 1,4-dihidropiridindicarboxilicos.
DE3882135D1 (de) Verwendung von melatonin oder seine derivate zur herstellung von arzneimitteln, die gegen alterskrankheiten wirksam sind.
DK561089D0 (da) Anvendelse af lactamimider til fremstilling af laegemidler
NO890046L (no) Disubstituerte pyridiner.
IT1216772B (it) Derivati di indolo ,procedimento per prepararli e composizioni farmaceutiche che li contengono per il trattamento di emicrania
IT1263957B (it) Impiego terapeutico del pirrolidon carbossilato di piridossina
MX26167A (es) Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino.
ES2065737T3 (es) Derivados de acido mandelico substituidos como inhibidores de 5-lipoxigenasa.
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
FI65616B (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara 1-oxadiazolylfenoxi-3-(4-fenylpiperazinyl)-propanol-2-derivat
IT1159101B (it) Procedimento per il trattamento del la colibacillosi neonatale e relativo composto farmaceutico
SE8403659D0 (sv) Synergistic pharmaceutical composition
IT8120772A0 (it) Procedimento per modificare i prodotti in fibra animale strappando le scaglie.
IT8219650A0 (it) Derivati dagli acidi alfa o beta mercaptopropionilammidoacetici, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
IT1143012B (it) Composti 6-aril pirimidinici per il trattamento e la prevenzione di infezioni virali e per stimolare la produzione di interferone
ES2055440T3 (es) Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
DE3879837D1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 525568

Country of ref document: ES